POPULARITY
Categories
Send us a textHealthcare spending continues to surge, with pharmacy costs now representing 30-40% of total healthcare spend. In this episode of CareTalk Executive Features, David Williams speaks with Dr. Alan Pannier, SVP of Product Strategy at SmithRx, about how legacy PBMs' misaligned incentives drive up costs, the toll on patients, employers, and independent pharmacies, and how a modern PBM model focused on transparency, fair reimbursement, and aligned incentives could finally fix what's broken in pharmacy benefits.
Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, joined Over the Counter to discuss her role in drafting new guidelines that help bolster the authority of critical care pharmacists across the country.
While doctors are prescribing fewer and fewer opioids, there's one that's not going away – buprenorphine, often known by its brand name of Suboxone. Compared to other narcotics, it's harder to abuse. It's far less dangerous than the synthetic street drugs. And it reduces the risk of overdosing. But it's still an opioid that is very hard to get off of. The number of Tennesseans prescribed these opioids as addiction treatment jumped by 40% in just five years. As we look this week at all sides of a philosophy known as “harm reduction,” today we focus on access to the opioids meant to get us out of the opioid crisis.GuestsLeslie Cole, MD, addiction physician, Springfield, Tenn.Josh Draper, program manager, Sumner Prevention CoalitionTracy Frame, PharmD, professor of pharmacy practice and director of the Flourish Mobile Clinic, Belmont UniversityChap Cuthbert, community response peer support, Mental Health Cooperative
On this episode, we define anemia and describe its clinical presentations, classifications, and underlying etiologies. We evaluate current guidelines and evidence-based strategies for diagnosing and managing different types of anemia, including iron-deficiency, vitamin B12/folate-deficiency, and anemia of chronic disease. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
This is a fascinating podcast episode from Dr. Lipid himself on desmosterol. What is it? How do we measure it? Why should we care? Pharmacists are well-positioned to guide patients in understanding the role of desmosterol, how medications may influence its levels, the options for measuring it, and the steps to take if levels are too high or too low. Dr. Thomas Dayspring: linkedin.com/in/thomas-dayspring-md-facp-fnla-3aaa876 or @DrLipid on X Tamara Ruggles, PharmD: linkedin.com/in/tamara-ruggles-491882251 Resource on lipids recommended by Dr. Dayspring: https://familyheart.org/ Wages PA, Kim HH, Korade Z, Porter NA. Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol. J Lipid Res. 2018 Oct;59(10):1916-1926. doi: 10.1194/jlr.M086991. Epub 2018 Aug 7. PMID: 30087204; PMCID: PMC6168312. Available at: https://pubmed.ncbi.nlm.nih.gov/30087204/ The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.
Jasmine Gonzalvo, PharmD, MPH, CDCES, FADCES, and Honey Yang Estrada, MPH, CHW, join this episode to discuss the vital role of community health workers (CHWs) in diabetes care. They share strategies for recruiting CHWs, integrating them into interprofessional care teams, and leveraging their lived experience to build trust and address barriers beyond the clinic walls. The conversation emphasizes listening to CHWs, fostering sustainable partnerships, and shifting power to communities—not just checking a box—to reduce disparities and drive better outcomes. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Samuel Yamshon, MD The treatment landscape for large B-cell lymphoma (LBCL) is rapidly evolving due to the growing integration of bispecific antibodies into second-line care. While these agents offer promising, targeted options—not only for patients ineligible for CAR T-cell therapy, but also as complementary strategies in combination with chemoimmunotherapy—they raise important questions around sequencing, durability, and patient selection. Joining Dr. Charles Turck to explore the real-world implications of this evolving approach is Dr. Samuel Yamshon, Director of the Cellular Therapy Service and an Assistant Professor of Medicine at Weill Cornell Medicine in New York.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sairah Ahmed, MD CAR T-cell therapies have helped transform the treatment of aggressive lymphomas, but could they also change the game for slower-growing, harder-to-treat diseases like marginal zone lymphoma? Based on new data from the TRANSCEND FL study, liso-cel achieved a 95 percent overall response rate and sustained 24-month progression-free survival in relapsed/refractory marginal zone lymphoma. Here with Dr. Charles Turck to share the key efficacy and safety findings is Dr. Sairah Ahmed, Professor in the Department of Lymphoma and Myeloma and CAR T Program Director at MD Anderson Cancer Center.
Abby Frye, PharmD, BCACP, Clinical Pharmacy Specialist,Primary Care, Providence Medical Group, Providence St. VincentCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ywBS3NqHMf (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 9, 2025End Date: September 9, 2026
Abby Frye, PharmD, BCACP, Clinical Pharmacy Specialist,Primary Care, Providence Medical Group, Providence St. VincentCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ywBS3NqHMf (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 9, 2025End Date: September 9, 2026
I've done episodes about dietary supplements. I didn't take into account the ones sold at the gas station or corner store. People with an anxiety condition or disorder should be very careful about promises of herbal supplements treatment. I don't want to be elitist here. There is bad stuff in U.S. pharmacies that do not work, known not to be effective or dangerous and yet still on sale. I have examples from Ethan Melillo. PharmD and Grant Harding, PharmD. It is one thing to buy Slim-Jims from the gas station. I've bought water, two cans for three dollars then I get to the counter where the person looks at me like I'm less than dirt as he rings me up. Then I remember not to go back into that store for the next eight months or so. I would never, ever purchase an herbal supplement from the gas station store, a convenience store or the 99 Cents or 150 Cents Store-ish variations. You might decide otherwise. If you do want to risk it, pack a magnifying glass because you have to read the label. What is the dosage? It might not be the full bottle. And most important, have the contents been verified by an independent industry respected testing organization? We need to be careful out in the wild. Just my two cents. This is my opinion which ain't worth a bucket of salt. Which does not stop me from this episode on how to evaluate herbal health supplements. Resources Mentioned: Operation Supplement Safety is intended for folks in the military that have restrictions on the kind of supplements they can use. However there is a non-military consumer version of the OSS Postcard that is a PDF download that gives guidelines on how to evaluate a supplement. U.S. National Institutes of Health Office of Dietary Supplements (ODS), National Institutes of Health (NIH) Dietary Supplements: What You Need to Know updated January 2023. National Center for Complementary and Integrative Health page called Herbs at a Glance and Using Dietary Supplements Wisely U.S. Food and Drug Administration (FDA) FDA page on Information for Consumers on Using Dietary Supplements, updated 2022. FDA page on Health Fraud Products Database. You can search by name, vendor, website or a specific action taken by the FDA. Emergency Resources The Trevor Project: Provides crisis support specifically for LGBTQ+ youth through phone (1-866-488-7386), text (START to 678-678), and online chat. Available 24/7. They also provide peer support and community. Veterans Crisis Line: Call 988 and press 1, text 838255, or chat online. There are phone lines for those serving overseas. Visit the website to find the current status of the Veteran line and international calling options. National Crisis Text Line: Text HOME to 741741 for free, confidential support 24/7. This service operates independently of the 988 service. Users can use text, chat or WhatsApp as a means of contact. Disclaimer: Links to other sites are provided for information purposes only and do not constitute endorsements. Always seek the advice of a qualified health provider with questions you may have regarding a medical or mental health disorder. This blog and podcast is intended for informational and educational purposes only. Nothing in this program is intended to be a substitute for professional psychological, psychiatric or medical advice, diagnosis, or treatment.
Take a stroll with me down memory lane. Reminiscing how brutal life can be as a 2022 PharmD graduate (through my lense). In a nutshell We suffered, we bled, we conquered. But the details matter most because we've been branded the bad guy. Let's unravel just how bad we are.Journal by the PSGH about the RX22 brouhaha - https://ghanapharmaceuticaljournal.com/news/rx22-and-the-housemanship-injustice-a-turbulent-fight-for-financial-clearance-marked-by-hope-and-despair/Induction of Pharmacists in May 2023 (Start from 4:37:37) - https://www.youtube.com/live/-XTPC6pODow?si=ysmRGso2vrzz8_l_Be the judge
“All of these TKIs [tyrosine kinase inhibitors] inhibit BCR-ABL1 in some way, shape, or form. When BCR-ABL1 is mutated, it has uncontrolled tyrosine kinase activity, leading to rapid cell proliferation. When we then inhibit that BCR-ABL1 that's been mutated, we disrupt this abnormal signaling pathway that drives CML [chronic myeloid leukemia] cell proliferation and survival, ultimately leading to decreased cancer cell growth, increased apoptosis or cell death, and potentially inducing a disease remission,” Samantha Maples, PharmD, BCOP, clinical pharmacy specialist supervisor for hematology and cellular therapy at Allegheny Health Network in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the BCR-ABL1 inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 5, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of BCR-ABL1 inhibitors in the treatment of CML. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 322: Nursing Strategies to Reduce Readmission Rates for Patients With Cancer Episode 215: Navigate Updates in Oral Adherence to Cancer Therapies ONS Voice articles: Adherence to Oral Anticancer Medication Combination Therapy Shows Promise for Chronic Myeloid Leukemia The Case of the Medication Modification The Case of the Safety Session ONS course: Safe Handling Basics Clinical Journal of Oncology Nursing articles: Targeted Drug Therapies: Beyond Blood Counts and Chemistries Oncology Nursing Forum articles: Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors Fear of Progression in Outpatients With Chronic Myeloid Leukemia on Oral Tyrosine Kinase Inhibitors Other ONS resources: Biomarker Database Financial Toxicity Huddle Card Tyrosine Kinase Inhibitors Huddle Card Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation Oral Anticancer Medication Learning Library National Comprehensive Cancer Network National Comprehensive Cancer Network patient resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The IRIS study led to the approval of the BCR-ABL1 and TKI, imatinib, for CML in 2001 and completely changed the landscape of CML treatment. Then came the second-generation BCR-ABL1 TKIs: dasatinib in 2006, quickly followed by nilotinib in 2007. Thereafter came our second-generation, bosutinib, and our first approved third-generation TKI, ponatinib, both in 2012, which was a huge milestone as ponatinib overcomes resistance to the T315 I mutation, which no previously approved TKIs worked against.” TS 2:16 “The newest approved TKI, asciminib, is an allosteric inhibitor that binds to a different pocket on the BCR-ABL kinase via allosteric binding to the ABL myristoyl pocket. It's what's called a STAMP inhibitor, where STAMP stands for ‘specifically targeting the ABL myristoyl pocket.' And while all the TKIs target the BCR-ABL1 binding site, they can also inhibit different off-target kinases. And these differences in off-target inhibition are responsible for some of the different toxicities we see among the TKIs.” TS 4:51 “As a class, common toxicities include nausea; vomiting; diarrhea; cardiac toxicities, including cardiac arrhythmias and congestive heart failure; metabolic abnormalities such as hypercholesterolemia and hypertriglyceridemia; nephrotoxicity; hepatic toxicity; hemorrhaging and bleeding; as well as cytopenia. Individually, some of these agents are more likely to cause certain side effects compared to others, and there are unique toxicities associated with certain TKIs.” TS 8:10 “We've moved to using preemptive loperamide [in our clinic] for the first three days of starting treatment, because it's really hard to get patients to continue to take a medication if they have such severe diarrhea that they end up in the hospital or they're unable to leave their house. A lot of times, we will proactively give patients antiemetics and loperamide to help with the nausea, vomiting, and diarrhea. And then we can back off to an as-needed basis once they've been established on treatment. We can also use medications to help manage long-term complications that can require supportive care, such as statin therapy for high cholesterol, levothyroxine for hypothyroidism, anticoagulants for any venous thromboembolism, and antihypertensive medications for managing any new or worsening high blood pressure.” TS 12:44 “We are continually seeing these agents expand their indications to different lines of therapy, as well as more TKIs being approved for acute lymphoblastic leukemia. For example, asciminib just got approved in the frontline setting within the last year, whereas previously it was only approved in relapsed refractory setting. Last year, imatinib was the first BCR-ABL1 TKI to come out with a commercially supplied suspension option as well, which is huge in the pediatric space and [for] our adult patients who are unable to swallow tablets for other clinical reasons.” TS 21:22 “There is more information being published on the safe discontinuation of these medications with treatment-free remissions, and more information is coming out about who would be eligible and who can have the option to stop these treatments instead of having a lifelong chronic condition requiring continuous treatment. We're seeing more patients in clinical practice be able to stop BCR-ABL1 treatment, which has been a great development in CML.” TS 25:29
Tim Ulbrich and Tim Baker tackle one of the most common questions we hear from pharmacists: “Do I need this whole life insurance policy?” They dive into who needs coverage, common misconceptions, and why the “buy term and invest the difference” strategy may be the smarter approach. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD, and YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP®, tackle one of the most common questions we hear from pharmacists: “Do I need this whole life insurance policy?” We've seen an increasing number of pharmacists with expensive whole life insurance policies that are often complex, costly, and not always the best fit. In this video, Tim and Tim break down: ✅ Who actually needs life insurance (and who doesn't) ✅ The role life insurance should play in your financial plan ✅ The key differences between term life and whole life coverage ✅ Why “buy term and invest the difference” can often be the smarter strategy ✅ The conflicts of interest that sometimes drive whole life sales By the end, you'll better understand the benefits, costs, and misconceptions around whole life insurance so you can make an informed decision about what's right for your financial future. Mentioned on the Show Join APhA - Get 25% Off with Code YFP Life Insurance for Pharmacists: The Ultimate Guide Your Financial Pharmacist Your Financial Pharmacist on YouTube
On this episode of the PQI Podcast, we sit down with Jenny Hoang, PharmD, a 2024 graduate of the University of Texas at Austin and pharmacist at Texas Oncology. Jenny shares how her uncle's cancer diagnosis inspired her career — and how she's already making an impact through an innovative pilot program that brings the Five Love Languages into oncology care.This 6-week program, developed in collaboration with social workers, helps patients and their partners strengthen communication during treatment. The results have been powerful: reduced anxiety, greater emotional support, and even one couple saying it “saved their marriage.”In this episode, you'll hear:How love languages can be adapted into cancer care.Why pharmacists are uniquely positioned to support patients beyond medications.The measurable benefits patients and caregivers experienced from this pilot.How programs like this connect to NCODA's PQI mission of improving quality of life.
Effective management of adverse events and addressing barriers to care are critical to optimizing outcomes and maintaining quality of life for patients receiving CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Julia Lea Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator in solid tumor oncology at Atrium Health Levine Cancer Institute about proactive, team-based strategies to identify, monitor, and manage treatment-related toxicities in patients with early-stage and metastatic HR-positive, HER2-negative breast cancer. Dr. Ziegengeist sheds light on the patient journey, the roles of various multidisciplinary care team members, and useful resources for language and literacy barriers. “I think the biggest thing that is specific to CDK4/6 inhibitors is... eligibility criteria and when we're using the drugs in what setting, having those monitoring protocols and getting that multidisciplinary collaboration is really key.” – Julia Lea Ziegengeist, PharmD, BCOP Julia Lea Ziegengeist, PharmD, BCOP Clinical Pharmacist Coordinator, Solid Tumor Oncology Levine Cancer Institute Atrium Health Charlotte, NC Resources: ACCC Resource: CDK4/6 Inhibitors Management ACCC CDK4/6 Inhibitors Infographic
Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.
Enterocutaneous fistulas present one of the most complex challenges in clinical nutrition—and parenteral nutrition often plays a central role in management. In our latest episode, we're joined by Vanessa Kumpf, PharmD, leading expert in nutrition support, to discuss evidence-based strategies, real-world decision-making, and how to optimize outcomes for these high-risk patients.
The Plant Free MD with Dr Anthony Chaffee: A Carnivore Podcast
Follow Jason on Tik Tok @CarnivRX If you liked this and want to learn more go to my new website www.DrAnthonyChaffee.com
In this episode, our guest is Sam Libby, President and Managing Director of TCB Capital Advisors. Sam's long-standing career in healthcare investment banking has seen him lead over 30 impactful transactions, totaling more than $20 billion. His dedication to healthcare is rooted in a personal connection, being the son of two therapists, which has given him a unique understanding of the sector's challenges, particularly around patient access and care quality.As co-founder of TCB Capital Advisors, Sam focuses on empowering forward-thinking healthcare companies. His work spans partnerships with companies in oncology, neurodegenerative diseases, women's health, and digital health, helping to steer innovations that profoundly improve patient outcomes. Sam, welcome to the Talk to Your Pharmacist podcast. Now that our listeners have heard a bit about your background maybe you can fill in any gaps to that intro and share a bit about your personal life.Topics to discuss –Background & CareerSam, you've had an incredibly successful career in healthcare investment banking, leading over 30 transactions totaling more than $20 billion. Can you walk us through how you first became interested in the healthcare sector, and how your upbringing as the son of two therapists shaped your perspective on healthcare?As co-founder of TCB Capital Advisors, how did you identify the unique opportunity to focus specifically on healthcare companies? What challenges did you face in the early days of building your firm?Healthcare Investment LandscapeYou've been involved in transactions across diverse areas, such as oncology, neurodegenerative diseases, women's health, and digital health. How do you assess which healthcare innovations and companies are worth investing in? What are some key trends you're seeing in these sectors today?Healthcare investment banking involves navigating both financial and clinical challenges. How do you balance the business side of healthcare with the real-world impact on patient access and care quality?You've been part of some transformative partnerships in healthcare. Can you share a specific example of a partnership that particularly stands out to you, both in terms of financial success and its impact on patient outcomes?Healthcare Innovation & StrategyWith your experience empowering forward-thinking healthcare companies, how do you foresee digital health and technology playing a larger role in the future of patient care? What do you think are the biggest opportunities and challenges?Women's health is one of the key sectors you've focused on. What are some innovations or initiatives you've seen that are making a real difference for women's healthcare, and how can investors further support these efforts?In your opinion, what role does patient access play in the broader healthcare investment landscape? How can companies balance innovation with the need to make these innovations accessible to all patients, especially underserved populations?Financial Strategies & Healthcare CompaniesHealthcare investments often involve complex financial strategies. For our audience who might not be familiar with the intricacies of healthcare investment banking, can you explain how financial strategies differ when working with healthcare companies as opposed to other industries?As a leader in healthcare investment banking, how do you guide companies through challenges like market volatility, regulatory hurdles, and competition in their efforts to innovate and grow? Are there any specific strategies you use to help them thrive?Future OutlookYou've helped shape the growth of companies across a wide range of therapeutic areas. Looking ahead, what sectors or healthcare innovations do you believe have the most potential to revolutionize patient outcomes in the next 5 to 10 years?As someone deeply involved in healthcare strategy and innovation, what advice would you give to young entrepreneurs or companies just starting to navigate the healthcare sector? What are the key lessons you've learned along the way?Lastly, what excites you most about the future of healthcare, and where do you see the biggest areas for disruption and opportunity?Guest - Sam Libby, TCB Capital AdvisorsHost - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/ ★ Support this podcast on Patreon ★
Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Asking for and getting a raise can make a significant difference in your financial plan for years to come. In this episode, Tim Ulbrich walks through a five-step playbook with practical tips and strategies to help you confidently ask for and get the raise you deserve. Episode Summary Asking for and getting a raise can make a massive difference in your financial plan, not just today, but for years and even decades to come. For many pharmacists, the thought of walking into their boss's office and asking for more money can feel as unpleasant as getting a cavity filled. It's uncomfortable, awkward, and full of “what ifs”: What if they say no? What if I ruin the relationship? What if they think I'm being greedy? The truth is, most people never get a big raise for one simple reason: they never ask. And that “ask” isn't just about adding dollars to your paycheck. It's about building confidence and advocating for the value you bring to your role. In this episode, YFP Co-Founder & CEO, Tim Ulbrich, PharmD, breaks down a five-step playbook with practical examples, real-world negotiation tips, and a few favorite strategies from Chris Voss's Never Split the Difference. Whether you're aiming for your first raise or looking to boost your income long term, this episode gives you the tools to confidently ask for and actually get the raise you deserve. Mentioned on the Show YFP YouTube Channel YFP 384: Beyond Salary: Negotiating Your Value in the Workplace Never Split the Difference by Chris Voss Your Financial Pharmacist
Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginHow do you tackle one of healthcare's biggest challenges from behind the pharmacy counter?That's the question at the heart
Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss how pharmacy turnover rates impact independents, chains, and the patients they serve.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Evandro Bezerra, MD As CAR T-cell therapy advances, so does the complexity of adverse event monitoring. Due to evolving insights into acute toxicities, infections, cytopenias, and secondary malignancies, both inpatient and outpatient care models are adapting to meet new standards. Joining Dr. Charles Turck to discuss practical strategies and emerging tools for managing post-CAR T toxicities across the continuum of care is Dr. Evandro Bezerra, Clinical Assistant Professor at Ohio State University Comprehensive Cancer Center in Columbus.
On this episode, we define obsessive-compulsive disorder (OCD) and describe its clinical presentations, diagnostic criteria, and underlying pathophysiology. We evaluate current guidelines and evidence-based treatment strategies for managing OCD, including pharmacologic and non-pharmacologic interventions. We also, compare and contrast the efficacy, safety profiles, and appropriate use of selective serotonin reuptake inhibitors (SSRIs), cognitive behavioral therapy (CBT), and other emerging treatment modalities for OCD. Dr. David Osser's psychopharmacology Algorithm Website Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
On episode 525 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews author and lactation pharmacologist Dr. Kaytlin Krutsch, PhD, PharmD, MBA, BCPS. In the course of their conversation, Keith and Dr. Krutsch discuss the history and science behind the very specialized topic of lactation pharmacology, and why it should be of great importance to all healthcare professionals. Kaytlin Krutsch, PhD, PharmD, MBA, BCPS is a lactation pharmacologist who literally wrote the book on medications in human milk with Dr. Thomas Hale, Hale's Medications and Mothers' Milk. Dr. Krutsch is both Director of the Infant Risk Center and Associate Professor at the Texas Tech University Health Sciences Center, and advises the Food and Drug Administration, the Human Milk Banking Association of Northern America, and the pharmaceutical industry on lactation pharmacology and lactation research. Dr. Krutsch believes families deserve better answers to questions about breastfeeding and medications, and designs research that addresses their questions while creating a comprehensive information cycle that empowers families. This episode of the Nurse Keith Show is brought to you in collaboration with Springer Publishing, who have been delivering award-winning healthcare education and exam prep materials focused on nursing, behavioral health, and the health sciences for more than 70 years. We thank Springer Publishing for their support. Connect with Dr. Kaytlin Krutsch and The Infant Risk Center LinkedIn Instagram Facebook Infant Risk Center website Hale's Medications and Mother's Milk Contact Nurse Keith about holistic career coaching to elevate your nursing and healthcare career at NurseKeith.com. Keith also offers services as a motivational and keynote speaker and freelance nurse writer. You can always find Keith on LinkedIn. Are you looking for a novel way to empower your career and move forward in life? Keith's wife, Shada McKenzie, is a gifted astrologer and reader of the tarot who combines ancient and modern techniques to provide valuable insights into your motivations, aspirations, and life trajectory, and she offers listeners of The Nurse Keith Show a 10% discount on their first consultation. Contact Shada at TheCircelandtheDot.com or shada@thecircleandthedot.com.
Celebrate the American Diabetes Association®'s (ADA) 85th anniversary with Drs. Neil Skolnik and Sara Wettergreen, joined by Dr. Marlon Pragnell, Charlene Wallace, and Stacey Krawczyk. Together, they'll reflect on the ADA's legacy of groundbreaking research and how it continues to shape the programs and resources available today. The conversation will also highlight practical tools—from nutrition guidance to the National Diabetes Prevention Program—to support you and your loved ones in managing or preventing diabetes. Because it all matters. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Charlene Wallace, MBA, Vice President of Diabetes Prevention at the ADA Stacey Krawczyk, MS, RD, Director of Nutrition and Wellness at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Additional resources: Research Impact Learn More About the National Diabetes Prevention Program Eating for Diabetes Management Diabetes Food Hub More on the ADA's 85th Anniversary
The Future Is Now: APhA President Randy McDonough on Leading Change in Independent PharmacyWhat does the future of independent pharmacy look like—and how do we get there?In this powerful episode of Independent Insights, APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Randy shares his frontline perspective as both a national leader and a practicing owner.Whether you're a pharmacist, technician, or pharmacy owner, this episode will leave you inspired, informed, and ready to take action. Tune in and be part of the movement to redefine the role—and the value—of independent pharmacy in healthcare.HostSuzanne Feeney, PharmDSenior Director, Pharmacy SolutionsMcKesson/ Health MartGuestsRandy McDonough, PharmD, MS, BCGP, BCPS, FAPhAPresident, American Pharmacists Association (APhA) and Health Mart Pharmacy OwnerNancy Lyons, BSPharm, MBA, CDCESVice President, Chief Pharmacy OfficerMcKesson/ Health MartResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for: Helpful CE courses, advanced trainings, and more Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.
Independent Rx Forum host John Beckner is joined by Jessi Stout, PharmD, owner of Table Rock Pharmacy in Morganton, N.C. who is among those featured in the August issue of America's Pharmacist®. She shares her journey into community pharmacy and how she weathered Hurricane Helene while supporting her community through the aftermath.
When you think about building wealth in medicine, do you picture yourself working at one job until retirement? My guest today, Kristin Burton, proves there's a better way. She began her career like many of us, buried in student loan debt and working long hours. After paying off $161,000 in just 16 months, she realized financial freedom was about more than debt elimination. Kristin shares how she shifted her focus from paying bills to building assets, investing aggressively in her twenties, and eventually creating income streams outside of medicine. We talk about the mindset shifts healthcare professionals must make to get ahead, and Kristin also shares how she helps other PAs, NPs, and PharmDs rethink their financial journey, create sustainable wealth, and avoid burnout in medicine. If you're wondering whether it's possible to thrive in your career, grow your wealth, and still have time for family and passions, this episode is for you! “If you can create a gap between your expenses and income and then create some assets with the gap, it's almost inevitable that you're gonna end up building some wealth.” ~ Kristin Burton In This Episode:- Kristin Burton's journey of paying $161k in student debt- What steps did she take toward becoming a millionaire?- Why your income level doesn't matter in building wealth- What Kristin would do differently and her current beliefs- Biggest client "head trash": PSLF myths and the 4% 401k mindset - How do you help healthcare professionals avoid lifestyle inflation?- Kristin's book recommendations - Redefining wealth: from net worth goals to "what is enough?" - How to find out more and join Kristin's community Book Recommendations Mentioned in the Episode: The Alchemist by Paulo Coelho: https://a.co/d/3yayzkg 10x Is Easier Than 2x by Dr. Benjamin Hardy & Dan Sullivan: https://a.co/d/hlbLEbG Who Not How by Dr. Benjamin Hardy & Dan Sullivan: https://a.co/d/2Ol8RjwThe 5 Types of Wealth by Sahil Bloom: https://a.co/d/6SMYeNH Die With Zero by Bill Perkins: https://a.co/d/6ae8TSq Join The Millionaires in Medicine Club!Learn how to clear debt and build wealth as a PA, NP, or PharmD: https://www.millionairesinmedicine.com/community Connect with Kristin Burton: Website: https://www.millionairesinmedicine.com/ LinkedIn: https://www.linkedin.com/in/kristin-burton-pac `Resources:➡️ Free community of high-performing physicians: the Physician Wealth Accelerator - https://limitless-md.mn.co/➡️ Check out my programs - https://vikramraya.com/coaching/➡️ Apply to become a Limitless MD -
The Joint Commission's updated accreditation manual is designed to simplify requirements, enhance clarity, and better support healthcare organizations in survey preparation. In this episode of VerifiedRx, host Carolyn Liptak is joined by Dr. Robert Campbell of the Joint Commission and Diana Scott of Vizient to unpack the most significant changes. From the shift to National Performance Goals and medication safety priorities to the latest challenges in compounding, labeling, and hazardous drug handling, the conversation highlights practical insights to help pharmacy leaders stay compliant and survey-ready. Guest speakers: Robert Campbell, PharmD, BCSCP Sr. Director, Standards Interpretation, Accreditation Decision Management,Medication Safety Division of Accreditation and Certification Operations Joint Commission Diana Scott, MHA, RN, CPHQ Principal, Regulatory and Accreditation Services Vizient Host: Carolyn Liptak, , BS Pharm, MBA Vizient Show Notes: [01:16-01:51] Diana and Robert Backgrounds [01:52-02:43] Changes made to the hospital and critical access hospital manuals [02:44-03:09] Changes to the chapters themselves [03:10-04:08] National Performance Goals and elaborate on those that are relevant to medication safety and pharmacy services [04:09-05:15] The top medication management challenges [05:16-06:29] Pain management not being aligned and titration orders [06:30-06:56] Insufficient communication between pharmacists, prescribers and nurses when it comes to medication orders [06:57-08:02] Themes around labeling requirements for stored medications [08:03-08:46] Anything different in removing expired meds from patient care areas and in the pharmacy this area than previous years [08:47-10:58] Issues related to storing meds specifically per the package insert [10:59-11:55] Common issues seen inside the pharmacy regarding sterile compounding, noncompliance include hand hygiene, garbing, PPE, and cleaning and disinfecting [11:56-13:12] More specifics in those area the physical environment and facility cleanliness along with cleaning and disinfection practices [13:13-14:55] Explaination of how joint Commission defines and evaluates immediate use compounding [14:56-16:09] The minimum required elements for immediate use compounding competency [16:10-17:12] Compounding competencies besides immediate use [17:13-17:54] Expectations for environmental services training [17:55- 20:14] Concerns around hazardous drugs [20:15- 21:14] Additional information Links | Resources: Joint Commission: THE NEW STANDARD: Accreditation 360 VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed
On this episode, we define acute mania and describe its clinical presentations, underlying causes, and pathophysiology. We evaluate current guidelines and evidence-based treatment strategies for managing acute mania, including pharmacologic and nonpharmacologic interventions. We also compare and contrast the efficacy, safety profiles, and appropriate use of mood stabilizers, antipsychotics, and adjunctive therapies in the management of acute manic episodes. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
0:48: Intro 1:35: Common mistakes with inhalers 5:25: Tailoring inhaler education 9:10: Selecting the right inhaler for a patient 12:05: What an inhaler counseling session looks like 15:45: Tracking inhaler technique 18:06: Inhaler counseling in community pharmacies 21:24: Conclusion Jennifer Griffin, PharmD, MS, serves as a clinical pharmacist for Harps Food Stores, Inc., where she specializes in medical billing, point-of-care testing and treatment workflow, and marketing clinical services. She earned her Doctor of Pharmacy degree from Harding University College of Pharmacy in Searcy, Arkansas, and holds a Bachelor of Science in Healthcare Administration and a Master of Science in Health Promotion from the University of Central Arkansas.
In this episode of the We Talk Health podcast, West Tennessee Healthcare Henry County Hospital CEO, Paula Bell joins us. Paula recently became the new CEO of Henry County Hospital, and as a native of Henry County, she shares her journey and how she plans to lead.Learn all about what's new at Henry County Hospital, hear all about Paula's background and more.Guest:Paula Bell, PharmD, BCPSCEO, Henry County HospitalHost:Kara MobleySocial Media Coordinator
Today I am speaking with Dave Chase from Health Rosetta, and I'm asking Dave Chase three inferno-level burning questions—questions that, across the country, many self-insured employers are trying to find the answers to. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Now, an important underlying point that comes across loud and clear but remains unsaid, actually, in the conversation that follows is this: There are amazing brokers and EBCs (employee benefit consultants) and benefits advisors or TPAs (third-party administrators) who put their clients first and have the receipts (ie, they have data and they're willing to share it to prove this). And then there are those with the exact same titles, often enough, who are very much the opposite of this but super charming, I'm sure. I mean, it'd be a stretch to assume that the same roles don't apply to brokers or EBCs that apply for titles like hospital administrators where there's great ones and really not great ones; but everybody often gets lumped into the same category or even the term hospitals. Each of these terms is a broad stroke and contains multitudes. And do listen to the bonus clip from two weeks ago with Jonathan Baran for just more on this point. We dig into it for like 10 minutes or something. I also talk about this same concept in an upcoming episode with Mick Connors, MD. So, keep that underlying and unsaid theme in mind because a lot of these questions do boil down to, How do you figure out who's on the up-and-up and who's not? And if you need an example of the latter category, listen to the show with Ann Lewandowski (EP476) about the whistleblower lawsuit or the show with AJ Loiacono (EP379) about the myriad of brokers taking $7 or $14 per script written payable by the PBM (pharmacy benefit manager) and not reported on, as far as I know. This is very much still going on today, by the way, despite the CAA (Consolidated Appropriations Act) and the 5500 forms. Alright, so, first burning question, Question 1: After seeing J&J (Johnson & Johnson) and Wells Fargo sued for fiduciary breaches, what specific questions do I need to ask my benefits advisor to prove that my benefits advisor actually protects my interests? Okay, paraphrased, this question is employers trying to figure out what they can ask or how they can figure out if their benefits advisor or broker or employee benefit consultant is really as trustworthy as they'd like you to believe they are. There's been a whole bunch of shows that circle up on this. The thing is, though, the stakes are very, very high right now. So, yeah, I can see why this is turning into a burning question for anyone worried they might get sued personally unless they can figure out how to vet, for real in writing, who their broker, EBC, or advisor serves actually at the end of the day. Question 2 that I ask Dave Chase, and I'm not giving you the answers to these questions. You gotta listen to the show. But here's the second question I ask: How do I avoid personal liability when my TPA contract has hidden conflicts that could trigger an ERISA (Employee Retirement Income Security Act) lawsuit? Kind of a continuation of Question 1, but yeah, you can tell that self-insured employer teams are really digging in here and many, many are very aware of, first of all, the extent and depth of middle people doing things like, again, allegedly taking $20 million of employer clients' money and funding their executive bonus pool. So, yeah, definitely this is another doozy of a burning question. Also on these same topics, listen to the show with Justin Leader (EP433) and also the one with Cynthia Fisher (EP457) about spread pricing. Question 3 that I ask Dave Chase: My pharmacy costs keep climbing despite PBM guarantees. How do I tell if I am being systematically overcharged? Well, if your consultants are taking your rebates to fund their executive bonus pools, as I just mentioned there's a whole show about with Ann Lewandowski, or if they're taking $7 a script for every script that gets written for your members, which, yeah, that's afoot. I've seen the contracts and the cease and desists currently flying around our industry about that one. Or read that Osceola County lawsuit against their longtime brokers. Bottom line and end of this intro, informed employer teams are, for sure, wondering these questions. But even more than just wondering, what these questions signify to me, kind of at the macro level, they're realizing the danger of kind of sitting on that knowledge or just assuming that because everybody else is doing whatever, it's somehow safe—though status quo is getting kind of more and more dicey every single day. As some additional foreshadowing, this show finishes up with Dave Chase talking about the open-source resources that are available so that you too can create a high-performance health plan where members get higher-quality healthcare and, as Dave Chase says, the cost savings for free. There are links to many things that you can get from Health Rosetta and their sister company, Nautilus. Again, all the stuff is for free. Go to nautilushealth.org. That's their main Web site. Dave Chase, who has been on this podcast—I think this is his third time, although it has been a while—Dave Chase is co-founder and CEO of Health Rosetta. Also mentioned in this episode are Health Rosetta; Jonathan Baran; Mick Connors, MD; Ann Lewandowski; AJ Loiacono; Chris Deacon; VerSan Consulting; Justin Leader; Cynthia Fisher; Nautilus; Andreas Mang; Blackstone; Jon Camire; Claire Brockbank; Elizabeth Mitchell; Scott Haas; Paul Holmes; Chris Crawford; Luke Slindee, PharmD; Mark Cuban; Marilyn Bartlett, CPA, CGMA, CMA, CFM; Leah Binder; and Dawn Cornelis. You can learn more at Health Rosetta and follow Dave on LinkedIn. Dave Chase is on a mission to restore hope, health, and economic well-being to communities through healthcare transformation. As creator of the community-owned health plan (COHP) model, he is building a nationwide movement that turns health plans from drivers of wage stagnation into vessels for well-being and wealth creation. As founder of Health Rosetta, Dave has helped transform healthcare for thousands of employers covering more than five million Americans. What began with identifying just five successful health plans nationwide has grown into a movement with thousands of sustainable successes that deliver superior care at 20% to 50% lower costs. In 2024, his team launched Nautilus Health Institute, catalyzed with $4 million in Health Rosetta intellectual property and investment. Nautilus provides open-source standards, contracting templates, and technology infrastructure (including METL, an open-source healthcare data platform) that establish new market norms benefiting employers, clinicians, and communities. Dave's work in healthcare transformation has reached over 10 million people through best-selling books (The CEO's Guide to Restoring the American Dream, The Opioid Crisis Wake-up Call, Relocalizing Health), media, TED Talks, and TV/film appearances. He has received the World Health Care Congress's Lifetime Achievement Award for Health Benefits Innovation. Dave is dedicated to transforming healthcare through transparency, community ownership, and proven solutions that restore the American Dream. 06:36 What questions does a plan sponsor need to ask their consultant, EBC, or broker to ensure they are protecting the interest of the plan sponsor? 07:59 EP478 with Andreas Mang and Jon Camire. 08:49 EP453 with Claire Brockbank. 09:51 EP433 with Justin Leader. 09:53 EP436 with Elizabeth Mitchell. 11:03 How can plan sponsors avoid personal liability when their TPA has hidden conflicts of interest? 11:40 Tiara Yachts v. Blue Cross Blue Shield of Michigan lawsuit. 13:48 EP483 (Part 1) with Jonathan Baran. 14:18 EP457 with Cynthia Fisher. 16:18 The Marshall-Hickenlooper bill called the Price Tags Act. 16:50 Summer Short with Elizabeth Mitchell. 17:36 How do plan sponsors figure out if they are being overcharged for pharmacy benefits? 18:09 EP365 with Scott Haas. 20:18 EP397 with Paul Holmes. 20:22 EP465 with Chris Crawford. 20:37 EP429 with Luke Slindee, PharmD. 22:56 EP476 with Ann Lewandowski. 28:38 Where to find open-source resources to help guide plan sponsors with making better health plan decisions. 29:47 How the open-source trend is growing for health transparency. 30:48 What to look forward to at RosettaFest. You can learn more at Health Rosetta and follow Dave on LinkedIn. @chasedave discusses questions #plansponsors need to ask on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation Recent past interviews: Click a guest's name for their latest RHV episode! Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander, Dr Tom X Lee (Take Two: EP445), Dr Tom X Lee (Bonus Episode), Dr Benjamin Schwartz, Dr John Lee (Take Two: EP438), Kimberly Carleson, Ann Lewandowski (Summer Shorts), Andreas Mang and Jon Camire (EP479)
In this special episode, Tim Ulbrich introduces the winners of the YFP Gives scholarship. Deja Preusser, Zipporah Williams, Michaela Martin-Worley, Julia Miller, and Mildred Asamoah share their inspiring stories, showcasing the drive, resilience, and vision of the next generation of pharmacy leaders. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD introduces the five recipients of the 2025 YFP Gives Scholarship. These inspiring stories reflect the passion, perseverance, and leadership of the next generation of pharmacy professionals. The 2025 YFP Gives scholarship winners are Deja Preusser, Zipporah Williams, Michaela Martin-Worley, Julia Miller, and Mildred Asamoah. Now in its second year, the YFP Gives Scholarship provides each winner with a $1,000 scholarship, 1-year access to YFP+, a copy of Seven Figure Pharmacist, and a 1:1 Ask Me Anything session with Tim Ulbrich or Tim Baker. Mentioned on the Show YFP YouTube Channel YFP Gives Your Financial Pharmacist
In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics' latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030. Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk's semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.The Evolution of GLP-1swww.primetherapeutics.comAll Pharmacy Friends episodesMetabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver healthThe views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice
Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginHow do you grow from one pharmacy to 32...and still sleep at night?That's a question unicorn pharmacy owners can answer and this week we're joined by one!In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA and Austin Murray sit down with Bill Osborn, President at Osborn Drugs and pharmacy industry veteran, for an unscripted, insightful conversation that spans decades of wisdom, wit, and work ethic.From navigating PBM reform and workforce shortages to embracing AI and technology, we jump into the "Pharmacy Time Machine" to discuss:- The evolving role of AI and automation in pharmacy- How Bill built a 32-store network rooted in local ownership- Partnership structures, buy-sell agreements, and long-term sustainability- And more!More About Our Guest: Bill Osborn is President of Osborn Drugs, Inc. and started working in the pharmacy in different capacities since the age of 13. A Miami OK native, Bill graduated from Miami High School (1978) and received his Associates degree (1980) from NEO A&M College. He obtained his Bachelor (1984) and Doctorate of Pharmacy (2003) from the University of Oklahoma.He currently serves as co-chair of Unify Rx and is on the board of AlignRx. Bill also serves on the board of directors of Surescripts, LLC, the Premier Value Alliance, and First National Bank of Miami. Bill served a 10-year term on the Oklahoma State Board of Pharmacy and is a current member of the Oklahoma Pharmacists Association and the American College of Apothecaries. Bill is a graduate of University of Oklahoma College of Pharmacy.Connect with Bill Osborn and Osborn Drugs: Bill Osborn LinkedInProRx WebsiteOsborn Drugs WebsiteOsborn Drugs FacebookStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - PBM Reform Act and Medicare Drug Pricing Changes
Samantha Picking, PharmD, joined Over the Counter to discuss her role as Walgreens' senior director of immunizations during National Immunization Awareness Month.
We chat about neuromuscular blockade, monitoring, and reversal in the ICU, including why sugammadex isn't more widely used, with Sara J Hyland, PharmD, BCCCP, FCCP, researcher and clinical pharmacist in perioperative and emergency medicine. Learn more at the Intensive Care Academy! Takeaway lessons References
In this episode: Randy Lipps is Chairman, President, Chief Executive Officer, and Founder of Omnicell, a leader in transforming the pharmacy care delivery model. Under his leadership, Omnicell has grown from a single product offering to delivering the most comprehensive portfolio of medication management solutions across the continuum of care.Mr. Lipps founded Omnicell in 1992 after observing how inefficiently medical supplies were managed when his daughter was hospitalized at birth. Inspired by his work in airline industry operations and logistics, he sought to enable better management of supplies and medications to help improve patient care.Omnicell became a publicly traded company in August 2001, and today healthcare systems worldwide leverage the company's automation and advanced services offerings to maximize clinical and operational outcomes.In 2014 Mr. Lipps was elected to the Bellwether League Hall of Fame, an industry organization that honors healthcare supply chain innovators, pioneers, and visionaries.Mr. Lipps has made giving back to the community a priority at Omnicell. Omnicell Cares, the company's formalized charitable efforts program, translates this into action, making a positive difference by fostering opportunities for volunteerism, charitable giving, and raising awareness for critical topics and issues. Mr. Lipps and his wife, Kathy, have focused their own philanthropy on poverty, nursing and public education, pharmacy research, youth groups, and local community efforts. Mr. Lipps serves as a member of the Board of Trustees of the American Nurses Foundation.Prior to founding Omnicell, Mr. Lipps was Assistant Vice President of Sales and Operations for a division of American Airlines. He holds Bachelor degrees in both Economics and Business Administration from Southern Methodist University. Topics to discuss –Introduction to Randy and Omnicell and his journey leading the digital transformation of medication management Staffing shortages and employee retention are top problems facing employers today, especially hospitals and health systems. In the pharmacy, labor shortages have far-reaching impacts including reduced quality of patient care, increased workloads for staff, slow delivery of medications, growing operational costs and process inefficiencies that lead to medication errors. Automation for pharmacies could be the key to addressing these issues and optimizing hospital staff's efficiency to reduce labor gaps.How the Innovation Lab allows customers to get a firsthand look at how automation technologies can make their healthcare operations more efficient and enable nurses and pharmacists to spend more time caring for patients. The autonomous pharmacy vision. How pharmacy automation reduces medication errors through accurate dispensing, streamlines inventory management and real-time tracking, ensures controlled substance security and regulatory compliance, and gives nurses more time to focus on higher-value tasks that directly impact patient care.Guest - Randall Lipps is Chairman, President, Chief Executive Officer, and Founder of OmnicellSocial Media:LinkedIn: https://www.linkedin.com/in/randall-lipps-a76412195/Website: https://www.omnicell.comYouTube: https://www.youtube.com/@Omnicell1Host - Hillary Blackburn, PharmD, MBAhttps://www.linkedin.com/in/hillary-blackburn-67a92421/ ★ Support this podcast on Patreon ★
In this episode of The Positive Pause®, host Claire Gill speaks with Dr. Adrienne Bitar, PhD and Dr. Jennifer Han, PharmD, BCACP, co-founders of Seen Nutrition about their personal experiences with bone health issues, including pre-menopausal osteoporosis, the important role of calcium in bone health & bone density, how to protect bone health at midlife, and the creation of their brand & its new calcium chew. Drawing from their personal and family experiences with osteoporosis, they created a food-first calcium chew, free of added sugars, synthetics, preservatives, and fillers, to help women protect their bones across all stages of life.Adrienne Bitar, PhD is a food studies researcher and lecturer in the Program in American Studies at Cornell University. She is the author of Diet and the Disease of Civilization (published by Rutgers University Press in 2018), a cultural history of diets in the US and analyzes how the obesity epidemic and diet book narratives reflect and shape broad cultural, religious, historical, and moral meaning. An expert in gender studies, food research, and the history of nutrition, Bitar has been widely consulted by journalists in the academic and popular press. Jennifer Han, PharmD is a Board-certified ambulatory care pharmacist (BCACP) practitioner at Syracuse Veterans Affairs Health System in New York, where she directs the chronic pain and whole health program. She has treated patients with full scope of practice to prescribe medications for chronic conditions such as diabetes, obesity, hypertension, dyslipidemia, pain and heart disease. Previously at Pomona Valley Hospital in Los Angeles, CA, Dr. Han created the first interdisciplinary clinical pharmacy practice at the Women and Family Medicine Clinic, as well as serving as clinical faculty of the Family Medicine Residency and residency coordinator for the Pharmacy Residency Program.Key Points CoveredPersonal Journeys & MotivationUnderstanding Bone Health Across the LifespanCalcium's Role in Bone HealthThe Problem with Traditional SupplementsPrevention & Early ActionPractical Advice for ListenersResources Available: Purchase your first order of the Seen Calcium Chew Complete - 1 Month Supply for only $35Bone Health and Osteoporosis Foundation (BHOF)International Osteoporosis Foundation (IOF)IOF Calcium CalculatorDr. Han and Dr. Bitar emphasize prevention, education, and smarter supplementation. Start now, start small, and prioritize your bones for lifelong strength and mobility.Connect with Dr. Bitar and Dr. Han: Website LinkedIn: https://www.linkedin.com/company/seennutrition https://www.linkedin.com/in/adriennerosebitar https://www.linkedin.com/in/jennifer-han-pharmd-bcacp FacebookInstagram
In this episode, our guest is Srulik Dvorsky, who is the co-founder and CEO of TailorMed. Drawing on his experiences caring for family members with cancer—and his background as a technological leader in the medical device space—he started TailorMed with a mission to remove barriers to care. Now the market's category leader, TailorMed offers the nation's largest affordability network spanning more than800 hospitals, 1,300 clinics, and 1,400 pharmacies, as well as premier life science companies. Under Srulik's leadership, TailorMed has received broad recognition for its impact and innovation, including Deloitte's Technology Fast 500 list and the New York Digital Health 100 list for three consecutive years. He holds a global MBA from the Arison School of Business at Reichman University and a BSc in electrical engineering from Tel Aviv University.Topics to discuss –1. Background on TailorMed, its mission, and its role for bringing down the cost of care for patientsFounding of TailorMed: After caring for several family members with cancer, Srulikwanted to leverage his expertise in technology to help solve a critical challenge in healthcare. He co-founded TailorMed in 2018 with a mission to help patients overcome barriers to care.2. Problem Overview: Affordability in Healthcare / Specialty Care:Rising medication costs lead many patients, particularly those who require specialty care, to delay or forgo therapy. About 1 in 5 U.S. adults says they have not filled a prescription, while 1 in 10 has cut pills in half or skipped doses in the last year,due to cost. This leads to higher rates of prescription abandonment and lossof revenue for pharmacies–and poor adherence and worseoutcomes for patients.3. How TailorMed Partners with Pharmacies:There is an abundance of financial assistance to help patients afford their medications, amounting to over $50 billion in total. These resources are underutilized because pharmacies and providers often lack a proactive approach to identify patients inneed and efficiently match them with assistance programs. TailorMed enables pharmacies and providers to flag financially at-risk patients and streamline program matching and enrollment. TailorMed began with provider partners and expanded to include top specialty pharmacies, infusion centers, and life science companies—building the nation's largest affordability network.4. Key Considerations for Pharmacy Teams Tackling MedicationAffordability:Streamline financial assistance workflows to proactively address cost barriers at scale.Embed affordability solutions into day-to-day operations to reduce administrative burden.Use data and automation to boost efficiency and support better patient outcomes.Prioritize change management and IT collaboration to ensure smooth adoption and long-term success of tech-driven solutions. Track both clinical and financial impact to refine your approachand promote best practices.Guest - Srulik Dvorsky, MBATailorMed's https://tailormed.co/ Srulik Dvorsky's LinkedIn: https://www.linkedin.com/in/srulik/ TailorMed's LinkedIn: https://www.linkedin.com/company/tailormed---medical-journey-innovations/ Host - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/ ★ Support this podcast on Patreon ★
Jasmine Gonzalvo, PharmD, MPH, CDCES, FADCES, joins this episode to discuss the importance of curiosity, effective communication and cultural sensitivity in diabetes care. She shares her personal approach to exploring barriers to insulin in clients and highlights how motivational interviewing can be a powerful tool in navigating treatment conversations—especially when addressing common misconceptions about insulin. The conversation emphasizes the importance of open-ended questions, recognizing personal biases, and creating safe spaces for honest dialogue. By nurturing relationships and meeting patients where they are, diabetes care and education specialists can better support lasting behavior change and improve health outcomes.This episode is sponsored by Lilly. ResourcesA link to the insulin myths tip sheet mentioned in this episode is coming soon. ReferencesNahid Dehghan-Nayeri, Fatemeh Ghaffari, Tahereh Sadeghi, Naser Mozaffari; Effects of Motivational Interviewing on Adherence to Treatment Regimens Among Patients With Type 1 Diabetes: A Systematic Review. Diabetes Spectr 1 May 2019; 32 (2): 112–117.Guy E H M Rutten, Heidi Van Vugt, Eelco de Koning - Person-centered diabetes care and patient activation in people with type 2 diabetes: BMJ Open Diabetes Research & Care 2020;8:e001926.Entwistle VA, Carter SM, Cribb A, McCaffery K. Supporting patient autonomy: the importance of clinician-patient relationships. J Gen Intern Med. 2010 Jul;25(7):741-5. doi: 10.1007/s11606-010-1292-2. Epub 2010 Mar 6. PMID: 20213206; PMCID: PMC2881979. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.
John Hertig, PharmD, MS, CPPS, FASHP, is Founder of Hertig Healthcare Advising and former faculty in the Pharmacy Practice Department in the Butler University College of Pharmacy and Health Sciences. He is also Past-President and a current Board of Directors member of the Alliance for Safe Online Pharmacies and is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. In this episode, he discusses his career, the online pharmacy landscape, the challenges and risks associated with illegal online pharmacies, how athletes and others can help keep themselves safe when accessing medications online, and more.
ASHP's senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include: Leveraging pharmacists' expertise to advance HIV treatmentPharmacist roles in HIV care and management The current ART landscapeRegimen simplificationConsideration of patient preferences, health factors, and comorbidities for ART optimizationART management for treatment-experienced patients, including those with multidrug-resistant HIVPresenters:Alexis E. Horace, PharmD, BCACPProfessor of Pharmacy PracticeUniversity of Louisiana at Monroe College of PharmacyNew Orleans CampusCrescentCare Ambulatory Care Clinical Pharmacist, HIV SpecialtyNew Orleans, LouisianaNimish Patel, PharmD, PhD, AAHIVPProfessor of Clinical PharmacyDivision of Clinical PharmacySkaggs School of Pharmacy & Pharmaceutical SciencesUniversity of California, San DiegoLa Jolla, CaliforniaLink to full program: https://bit.ly/41agtqQGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Guests:
Introducing Melissa Smith, PharmD, CPH, CPGx, Founder of Florida PGX Consulting, and the new host of the Precision Health and PGX Podcast! Dr. Melissa is joined by her guests Dr. Jamie Wilkey & Dr. Jackie Boyle to discuss their introduction to precision medicine in PGX, as well as their friendship that encouraged it!